Company / Cash per Share
Decoy Therapeutics Inc. Cash per Share History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.69
FY2022
5-year range
$0.55 / $6.69
FY2018-FY2022
Trend
+445.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +445% YoY in FY2022, a notable deviation from the 4-year average annual change of +166%.
Based on SEC 10-K filings.
6.69 in FY2022 with a 3-year CAGR of +53.8%.
Improved from $2.46 to $6.69 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +53.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share increased 445.2% year-over-year.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $6.69 | +445.2% |
| FY2021 | $1.23 | -50.2% |
| FY2020 | $2.46 | +34.0% |
| FY2019 | $1.84 | +233.0% |
| FY2018 | $0.55 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026